We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

7202:TSEIsuzu Motors Limited Analysis

Data as of 2026-03-14 - not real-time

SAR 179.60

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading beneath its short‑term and long‑term moving averages, reflecting a bearish price trend, while the relative strength index sits in oversold territory, hinting at potential upside. Technical momentum shows a bullish MACD histogram, suggesting a possible short‑term reversal, but volume is on a downtrend, indicating waning market participation. The company delivers a generous dividend yield well above four percent with a payout ratio comfortably below seventy percent, supporting income‑focused investors. Valuation metrics such as the price‑to‑earnings multiple are below the industry average, yet the price‑to‑book multiple remains elevated, positioning the stock in a mixed valuation zone. Fundamentally, the firm boasts a strong return on equity and a solid profit margin, but operating and free cash flow are negative, raising concerns about cash generation sustainability. The beta is exceptionally low, implying limited systematic risk, while the recent thirty‑day price volatility is high, reflecting pronounced price swings. Analyst consensus points to a sizable upside potential, and the market sentiment index is in a greed phase, indicating optimism. In sum, the dividend appeal and relative valuation attractiveness are offset by cash flow weakness and bearish technical signals, suggesting a cautious but opportunistic stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price below short‑term moving average
  • RSI in oversold zone
  • decreasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • PE multiple below industry average
  • high dividend yield
  • analyst target upside

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • strong return on equity
  • sustainable dividend policy
  • low beta and defensive sector positioning

Key Metrics & Analysis

Financial Health

Revenue Growth4.70%
Profit Margin11.80%
P/E Ratio14.3
ROE36.18%
ROA8.22%
Debt/Equity27.70
P/B Ratio5.0
Op. Cash FlowSAR-100669000
Free Cash FlowSAR-693491520
Industry P/E17.8

Technical Analysis

TrendBearish
RSI33.5
SupportSAR 170.10
ResistanceSAR 226.60
MA 20SAR 189.70
MA 50SAR 212.82
MA 200SAR 237.22
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Target PriceSAR 255.59
Upside/Downside42.31%
GradeFair
TypeBlend
Dividend Yield4.45%

Risk Assessment

Beta0.17
Volatility41.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.